COVID Update: Masks are still required in health care settings, even if you’re fully vaccinated. Read our FAQs.

2021 Updates in Diabetes Management Enduring Material

About This Activity

Program Overview

Scripps Whittier Diabetes Institute’s 2021 Updates in Diabetes Management internet enduring material provides the most recent medication, nutrition, and technology recommendations for managing patients with type 1 and type 2 diabetes.


Educational Objectives

After completing this internet enduring material, participants should be able to:

  • Describe special considerations and precautions necessary when treating patients with comorbid diabetes and heart disease.
  • Explain how to use and interpret new glucose monitoring technologies.
  • Review evidence-based approaches to weight loss and maintenance.
  • Identify and treat chronic kidney disease in patients with diabetes using the latest medications and guidelines.
  • Integrate new practice recommendations for the treatment of patients with diabetes from a PCP and specialist perspective.
  • Define the role of the interdisciplinary care team in caring for patients with type 1 and type 2 diabetes.


Course Directors

Athena Philis-Tsimikas, MD

Corporate Vice President

Scripps Whittier Diabetes Institute

La Jolla, California


Samantha Harris, MD

Endocrinologist, Scripps Clinic

Center for Weight Management

Scripps Whittier Diabetes Institute

La Jolla, California


Máire Robacker, RN, MSN, CDCES

Diabetes Clinical Specialist

Scripps Whittier Diabetes Institute

La Jolla, California

Topics and Speakers

2021: What’s New in Medications & Standards of Care

Lauren Vincent, MD

Scripps Whittier Diabetes Institute

                               

Matters of the Heart: Diabetes Effects on the Cardiovascular System

Darren McGuire, MD

UT Southwestern Medical Center

 

Diabetes Medications and Cardiovascular Outcomes

Darren McGuire, MD

UT Southwestern Medical Center

 

Glucose Targets and Heart Disease: Does A1c Matter?

Ildiko Lingvay, MD

UT Southwestern Medical Center

                               

Cardiac Protection: The Latest in Lipid and Antiplatelet Therapies

Harpreet Bhatia, MD

UC San Diego

                   

Updates in Renal Outcomes: SGLT2is and GLP-1 Agonists

Reza Elahimehr, MD

Scripps Clinic

                                       

Mastering Hypertension: Guidelines for Blood Pressure Management

George Bakris, MD

University of Chicago Medicine


The Future of Chronic Kidney Disease Management

Theresa Henke, MD

Cedars Sinai Medical Center

 

Integration of Devices, Billing for Techy Time, and the Future

David Ahn, MD

Hoag Memorial Hospital

 

Background on Diabetes Management and Weight

Samantha Harris, MD

Scripps Whittier Diabetes Institute

 

Eat Right, but Which Type? Diabetes, Weight Loss and Diet

Alex Bonnecaze, MD

Pinehurst Medical Clinic

 

A Tough Pill to Swallow, or Give it a Shot? Meds for Weight Loss

Karl Nadolsky, DO

Spectrum Health

 

Gut Instincts: Weight Loss Surgery and Diabetes

Cori McBride, MD

University of Nebraska Medical Center

 

Get Moving: Exercise for Weight Loss

Karl Nadolsky, DO

Spectrum Health

 

Behavioral Modifications and Weight Loss

Joe Kearney, MA, CLC

Scripps Clinic Center for Weight Management

Enduring Material Detail

Released On

November 29, 2021


Expires On

May 30, 2022


Media Type

Internet enduring material


Completion Time

7.5 hours


Credit Available

Maximum of 7.5 AMA PRA Category 1 Credit(s)™


Target Audience

This activity is intended for Primary Care Physicians, Physician Assistants, Nurse Practitioners, Pharmacists, Certified Diabetes Educators, Dieticians, and Other Allied Health Professionals caring for patients with diabetes.

Disclosure Policy

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, course directors, planners, moderators, faculty, and all others in control of the educational content of the continuing education activity must disclose all financial relationships with ineligible companies that they may have had within the past 24 months. If an individual refuses to disclose financial relationships, they will be disqualified from being a part of the planning and implementation of the activity. Owners and/or employees of an ineligible company with business lines or products relating to the content of the activity will not be permitted to participate in the planning or execution of any accredited program. All listed relevant financial relationships with ineligible companies for individuals in control of content have been mitigated.

 


Name

Role in Activity

Ineligible Company

Nature of Relevant Financial Relationship

Ahn

Speaker

  • Lilly Diabetes
  • Ascensia Diabetes Care, Senseonics
  • Xeris Pharmaceuticals, Zealand Pharma
  • Advisory Board, Speakers Bureau
  • Advisory Board
  • Speakers Bureau

Bakris

Speaker

  • AstraZeneca, Alnylam, Bayer, Ionis, Horizon, Merck, Vifor
  • Bayer, Novo Nordisk 
  • Consultant
  • Grant Support

Bhatia

Speaker

  • Gilead Sciences, Inc.
  • Stock

Bonnecaze

Speaker

  • None
  • N/A

Carrillo

Peer Reviewer

  • None
  • N/A

Elahimehr

Speaker

  • None
  • N/A

Harris

Course Director, Moderator, Speaker

  • Eli Lilly, Inc.
  • Zealand Pharma
  • Sanofi Aventis
  • Research
  • Speaker
  • Consultant

Henke

Speaker

  • None
  • N/A

Kearney

Speaker

  • None
  • N/A

Lingvay

Speaker

  • Boehringer‐Ingelheim, Novo Nordisk, Sanofi Aventis
  • AstraZeneca, Eli Lilly, Inc, Zealand
  • Janssen, TARGET Pharma, Valeritas
  • Bayer, Intercept Pharmaceuticals
  • Merck & Co, Mylan Pharmaceuticals, Pfizer, Sanofi Aventis
  • Advisor, Consultant, Research Funding
  • Advisor, Consultant
  • Consultant
  • Advisor
  • Research Funding

McBride

Speaker

  • Allurion
  • Data Monitoring Committee Member

McGuire

Speaker

  • AstraZeneca, Boehringer Ingelheim, Eisai, GlaxoSmithKline, Janssen, Lexicon, Lilly USA, Merck & Co, Novo Nordisk, Pfizer, Sanofi Aventis
  • Afimmune, Applied Therapeutics, AstraZeneca Boehringer Ingelheim, Merck & Co, Lilly USA, Metavant Sciences, Novo Nordisk, Sanofi Aventis
  • Clinical Trials Leadership
  • Consultant

Nadolsky

Speaker

  • None
  • N/A

Philis-Tsimikas

Course Director, Moderator

  • Dexcom, Eli Lilly, Inc, Novo Nordisk, Merck & Co, Medtronic, Sanofi Aventis
  • Advisory Board, Research

Robacker

Course Director

  • None
  • N/A

Vincent

Speaker

  • None
  • N/A

CME Committee

CE approval, all final decision-making on activities

  • None
  • N/A

Scripps Conference Services & CME

Plan, manage, implement, and reconcile CE activities

  • None
  • N/A

Accreditation and Conflict of Interest Mitigation 

Physicians

Scripps Health is accredited by the ACCME to provide continuing medical education for physicians.

 

Scripps Health designates this internet enduring material for a maximum of 7.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

 

Nurses and Nurse Practitioners

For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit(s)™ issued by organizations accredited by the ACCME.

 

For the purpose of re-licensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credit(s)™ for attendance at structured learning activities offered by organizations accredited by the ACCME.

 

The American Academy of Nurse Practitioners Certified Program (AANPCP) and the American Association of Nurse Practitioners (AANP) accept AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.

                                

Physician Assistants

PAs may claim a maximum of 7.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.

 

Conflict of Interest (COI) Mitigation

All relevant financial relationships with ineligible companies listed for individuals in control of content have been mitigated using a multi-step process including independent peer review of presentations.

Event details

Content Available

Mon, Nov 29, 2021 - Mon, May 30, 2022

Duration
7 hours, 30 minutes
Fee
$35.00